Summary
Updated Aug 31, 2026
Gail Boudreaux is President and CEO, Director of Elevance Health, Inc. (ELV). 4 SEC Form 4 filings on record going back to 2025, most recently on 17 July 2026. Most recent open-market trade: bought $753K of ELV on 17 July 2026. Lifetime open-market purchases: $3.44M. Historical track record: 5/5 stars across 3 tracked purchases.
Recent Transactions
10Every recent SEC Form 4 transaction Gail Boudreaux has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +7.04% |
| Avg 30-day return | +11.63% |
| Avg 90-day return | +25.66% |
| Best 30-day return | +11.63% |
Trading Pattern
InsiderAlpha's records for Gail Boudreaux go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $688K (5 buys totaling $3.44M). The largest single buy on record is $1.47M of ELV in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Gail Boudreaux files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Charles Morgan Kendrick Jr. - $911K of ELV open-market activity in the last 12 months
- Steven H. Collis - $870K of ELV open-market activity in the last 12 months
- Ronald W. Penczek - $766K of ELV open-market activity in the last 12 months
- Ramiro G. Peru - $366K of ELV open-market activity in the last 12 months
- Robert L. Dixon Jr. - $61K of ELV open-market activity in the last 12 months
- Amy W. Schulman - $7K of ELV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gail Boudreaux?
Gail Boudreaux is a corporate insider, tracked as President and CEO, Director of Elevance Health, Inc. (ELV). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gail Boudreaux submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gail Boudreaux been buying or selling stock?
Recorded transactions: 5 open-market purchases ($3.44M) and 0 open-market sales across all tracked filings.
How accurate is Gail Boudreaux's historical track record?
Across 3 tracked purchases, Gail Boudreaux averaged +11.6% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Gail Boudreaux's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gail Boudreaux and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial